Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosis

Adam Ceroi, David Masson, Anne Roggy, Christophe Roumier, Cécile Chagué, Thierry Gauthier, Laure Philippe, Baptiste Lamarthée, Fanny Angelot-Delettre, Francis Bonnefoy, Sylvain Perruche, Sabeha Biichle, Claude Preudhomme, Elisabeth Macintyre, Laurent Lagrost, Francine Garnache-Ottou, Philippe Saas

Blood (2016) 128 (23): 2694–2707.

https://doi.org/10.1182/blood-2016-06-724807

Published: 2016

Includes: Supplemental data

Journal Articles

Larger number of invariant natural killer T cells in PBSC allografts correlates with improved GVHD-free and progression-free survival

Florent Malard, Myriam Labopin, Patrice Chevallier, Thierry Guillaume, Alix Duquesne, Fanny Rialland, Sophie Derenne, Pierre Peterlin, Anne-Gaelle Leauté, Eolia Brissot, Marc Gregoire, Philippe Moreau, Philippe Saas, Béatrice Gaugler, Mohamad Mohty

Blood (2016) 127 (14): 1828–1835.

https://doi.org/10.1182/blood-2015-12-688739

Published: 2016

Includes: Supplemental data

Journal Articles

Splenic and Circulating Human T Follicular Helper Cell Regulation By B Cell Depleting Therapy during Immune Thrombocytopenia

Sylvain Audia, MD PhD, Marzia Rossato, PhD, Maxime Samson, MD PhD, Malika Trad, PhD, Kim Santegoets, PhD, Alexandrine Gautheron, PhD, Olivier Facy, MD PhD, Pablo Ortega-Deballon, MD PhD, Laurent Martin, MD PhD, Marion Ciudad, Nona Janikashvili, PhD, Philippe Saas, PhD, Timothy Radstake, MD PhD, Bernard Bonnotte, MD PhD

Blood (2015) 126 (23): 8.

https://doi.org/10.1182/blood.V126.23.8.8

Published: 2015

Journal Articles

Larger Number of Invariant Natural Killer T-Cells in Allogeneic Peripheral Blood Stem Cell Grafts Is Associated with Improved Graft-Versus-Host Disease-Free, Progression-Free Survival after Allogeneic Stem Cell Transplantation

Florent Malard, MD PhD, Myriam Labopin, MD, Patrice Chevallier, MD PhD, Thierry Guillaume, MD PhD, Alix Duquesne, Sophie Derenne, Eolia Brissot, MDPhD, Marc Gregoire, PhD, Philippe Moreau, Philippe Saas, PhD, Mohamad Mohty, MD PhD, Bbéatrice Gaugler, PhD

Blood (2015) 126 (23): 514.

https://doi.org/10.1182/blood.V126.23.514.514

Published: 2015

Journal Articles

Liver X Receptor Agonists: A Potential Treatment for Blastic Plasmacytoid Dendritic Cell Neoplasm

Adam Ceroi, PhDSTUDENT, Francine Garnache-ottou, PhD, Anne Roggy, PhDSTUDENT, Fanny Angelot-Delettre, PhD, Laure Philippe, MDcal student, Afag Asgarova, PhDstudent, Francis Bonnefoy, PhD, Cécile Chagué, SM Student, Sabeha Biichle, Jean-Paul Remy-Martin, ING, Claude Preudhomme, MD PhD, Christophe Roumier, MD, Elizabeth Macintyre, MD PhD, Laurent Lagrost, PhD, David Masson, PhD, Philippe Saas, PhD

Blood (2015) 126 (23): 4933.

https://doi.org/10.1182/blood.V126.23.4933.4933

Published: 2015

Journal Articles

How to Treat Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Patients : Results on 86 Patients of the French BPDCN Network

Eve Poret, Chrystelle Vidal, Yohan Desbrosses, Fanny Angelot Delettre, Maider Pagadoy, Aurore Pugin, Louis Benazet, Franck Leroux, Elise Robert, Delphine Binda, Sabeha Biichle, Anne Roggy, PhDSTUDENT, Laure Philippe, MDcal student, Berengere Gruson, Anne-Claire Gac, Michel Maigre, Denis Caillot, Remy Gressin, MD, Pascal Turlure, MD, Anne-Sophie Michallet, MD, Lila Gilis, Veronique Dorvaux, Yazid Arkam, Caroline Bonmati, MD, Pierre Péterlin, Pierre-Simon Rohrlich, MD PhD, Thorsten Braun, MD PhD, jean-Valere Malfuson, Didier Bouscary, MDPhD, Eric Pujade-Lauraine, Felipe Suarez, MD PhD, Carole Soussain, MD, Etienne Lengliné, MD, Mathieu Puyade, MD, Tony Marchand, MD, Denis Guyotat, Bruno Lioure, MD, Christian Recher, MD, Damien Roos-Weil, Fabrice Jardin, Jean-Pierre Marolleau, Bernard Drenou, MD, Bernard Bonnotte, MD PhD, Sophie Dalac, Philippe Saas, PhD, Francine Garnache Ottou, PhD, Eric Deconinck

Blood (2015) 126 (23): 456.

https://doi.org/10.1182/blood.V126.23.456.456

Published: 2015

Journal Articles

Biological Description of 109 Cases of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) from the French Network of BPDCN

Eve Poret, Fanny Angelot Delettre, Sabeha Biichle, Anne Roogy, Louis Benazet, Maider Pagadoy, Chrystelle Vidal, Franck Leroux, Véronique Harrivel, Christophe Ferrand, PhD, Veronique Salaun, Zehaira Benseddik, Julien Guy, Marie Christine Jacob, Christophe Roumier, Jean Feuillard, Liliana Vila, Lucile Baseggio, Adriana Plesa, Christine Arnoulet, B Benet, Bernard Drenou, MD, Veronique Latger Cannard, Marie-Christine Bene, MD, Michel Ticchioni, Daniel Lusina, Valerie Bardet, Magalie LE Garff Tavernier, Elizabeth Macintyre, MD PhD, Vahid Asnafi, MDPhD, Maria Elena Noguera, Sabrina Bouyer, Carine Lecoq Lafon, Mikael Roussel, MD PhD, Fabrice Jardin, Francoise Solly, MD, Lydia Campos, MD PhD, Anne Galoisy, Anne Arnaud, Sylvie Daliphard, Franck Genevieve, MD PhD, Romaric Lacroix, Françoise Schillinger, Estelle Seilles, Delphine Binda, Eric Deconinck, Philippe Saas, PhD, Francine Garnache Ottou, PhD

Blood (2015) 126 (23): 3812.

https://doi.org/10.1182/blood.V126.23.3812.3812

Published: 2015

Journal Articles

Splenic TFH expansion participates in B-cell differentiation and antiplatelet-antibody production during immune thrombocytopenia

Blood (2014) 124 (18): 2858–2866.

https://doi.org/10.1182/blood-2014-03-563445

Published: 2014

Journal Articles

Preclinical Studies Of SL-401, a Targeted Therapy Directed To The Interleukin-3 Receptor (IL3-R), In Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Potent Activity In BPDCN Cell Lines, Primary Tumor, and In An In Vivo Model

Delettre Fanny, PhD, Arthur E. Frankel, MD, Estelle Seilles, PhD, Sabeha Biichle, Bsc, Eric Deconninck, MD, Francis Bonnefoy, PhD, Baptiste Lamarthee, PhD Student, Christopher L. Brooks, PhD, Eric Rowinsky, MD, Philippe Saas, Ph.D., Francine Garnache Ottou, PhD

Blood (2013) 122 (21): 3942.

https://doi.org/10.1182/blood.V122.21.3942.3942

Published: 2013

Journal Articles

Preferential splenic CD8 + T-cell activation in rituximab-nonresponder patients with immune thrombocytopenia

Blood (2013) 122 (14): 2477–2486.

https://doi.org/10.1182/blood-2013-03-491415

Published: 2013

Includes: Supplemental data

Journal Articles

Plasmacytoid Dendritic Cells (PDC) and Th17 Immune Response Contribution in Skin Acute Graft-Versus-Host-Disease (GVHD)

Florent Malard, Céline Bossard, MD, PhD, Patrice Chevallier, MD, Thierry Guillaume, MD, Jacques Delaunay, MD, Eolia Brissot, Jean-François Mosnier, MD, Philippe Saas, Ph.D., Philippe Moreau, MD, Béatrice Gaugler, PhD, Mohamad Mohty, MD PhD

Blood (2012) 120 (21): 4103.

https://doi.org/10.1182/blood.V120.21.4103.4103

Published: 2012

Journal Articles

Failure of Rituximab in Immune Thrombocytopenia Is Associated with the Activation of Splenic CD8 T Cells

Sylvain Audia, M.D., Ph.D., Maxime Samson, M.D., Malika Trad, Ph.D., Nona Janikashvili, Ph.D., Denis Caillot, M.D., Laurent Martin, M.D., Ph.D., Bernard Lorcerie, M.D., Philippe Saas, Ph.D., Bernard Bonnotte, M.D., Ph.D.

Blood (2012) 120 (21): 623.

https://doi.org/10.1182/blood.V120.21.623.623

Published: 2012

Journal Articles

Plasmacytoid Dendritic Cells (PDC) and Th17 Immune Response Contribution in Gut Acute Graft-Versus-Host-Disease (GVHD)

Florent Malard, Céline Bossard, Jessy Arbez, Patrice Chevallier, MD, Thierry Guillaume, Jacques Delaunay, Jean-François Mosnier, Philippe Saas, PhD, Mohamad Mohty, Béatrice Gaugler

Blood (2011) 118 (21): 2968.

https://doi.org/10.1182/blood.V118.21.2968.2968

Published: 2011

Journal Articles

The IL-3Rα-Targeted Drug SL-401 Selectively Kills Blastic Plasmacytoid Dendritic Cell Neoplasm Cells

Fanny Angelot-Delettre, PhD, Arthur E. Frankel, MD, Jen Sing Liu, PhD, Estelle Seilles, PhD, Sabeha Biichle, Bsc, Bernard Drenou, MD, PhD, Mark L. Jacobson, MA, Thomas P. Cirrito, PhD, Arkam Yazid, MD, Eric Deconinck, MD, PhD, Christopher L. Brooks, PhD, Philippe Saas, PhD, Francine Garnache Ottou, PhD

Blood (2011) 118 (21): 2588.

https://doi.org/10.1182/blood.V118.21.2588.2588

Published: 2011

Journal Articles

Peripheral Blood Stem Cell Grafts Mobilized by G-CSF and Plerixafor in Comparison to G-CSF Alone: Phenotypic and Functional Characterization,

Béatrice Gaugler, J Arbez, J Frikeche, Steven Le Gouill, MD, PhD, Thomas Gastinne, Philippe Saas, PhD, Philippe Moreau, MD, S Derenne, Mohamad Mohty

Blood (2011) 118 (21): 4045.

https://doi.org/10.1182/blood.V118.21.4045.4045

Published: 2011

Journal Articles

Successful mobilization and engraftment of PBSCs derived from donor cord blood cells after a previous allogeneic RIC single unrelated cord blood transplantation

Fabrice Larosa, Eric Deconinck, Philippe Helias, Jean Fontan, Marian Heczko, Annie Brion, Katell Ledu, Philippe Delaby, Jacqueline Vuiller, Christophe Ferrand, Philippe Saas, Fabienne Pouthier, Anne Dormoy, Jacqueline Chabod, Caroline Malugani, Pierre S. Rohrlich, Faezeh Legrand

Blood (2011) 118 (2): 476–478.

https://doi.org/10.1182/blood-2011-03-343640

Published: 2011

Journal Articles

Infusion of Ex-Vivo Expanded Donor T Cells To Improve Graft-Derived T-Cell Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation.

Nicolas Montcuquet, BSc, Sylvain Perruche, PhD, Benjamin Shipman, Aliette Marandin-Decock, PhD, Francis Bonnefoy, BSc, Philippe Saas, PhD, Eric Robinet, PhD, Pierre Tiberghien, MD, PhD

Blood (2007) 110 (11): 3261.

https://doi.org/10.1182/blood.V110.11.3261.3261

Published: 2007

Journal Articles

Endothelial Cell-Derived Microparticules (EMPs) Can Induce In Vitro Maturation of Both Plasmocytoid and Myeloid Dendritic Cells.

Francine Garnache-Ottou, PhD, Fanny Angelot, Sabeha Biichle, Joel PLumas, PhD, Francoise Dignat George, PhD, Philippe Saas, PhD, Pierre Tiberghien, MD PhD, Estelle Seilles, PhD

Blood (2006) 108 (11): 1273.

https://doi.org/10.1182/blood.V108.11.1273.1273

Published: 2006

Journal Articles

Identification of BDCA-2 and High Levels of CD123 Expression as Useful Markers for the Diagnosis of Plasmacytoid Dendritic Cell Leukemia.

Francine Garnache-Ottou, PhD, Marie-Christine Jacob, MD, Sabeha Biichle, BSc, Laurence Chaperot, PhD, Franck Trimoreau, MD, Joel Plumas, PhD, Pierre Tiberghien, MD, PhD, Philippe Saas, PhD, Jean Feuillard, MD, PhD

Blood (2005) 106 (11): 3269.

https://doi.org/10.1182/blood.V106.11.3269.3269

Published: 2005

Journal Articles

Quality Assurance Improvement during Accreditation Process of a French Cord Blood Bank: FACT No Fiction.

Stephane Maddens, PhD, PharmD, Eric Petitprost, Isabelle Bardey, Christian Lamy, Francine Garnache, PhD, MD, Philippe Saas, PhD, PharmD, Jacqueline Chabod, Valerie Lapierre, PhD, MD

Blood (2005) 106 (11): 5284.

https://doi.org/10.1182/blood.V106.11.5284.5284

Published: 2005

NARROW

LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosis

Larger number of invariant natural killer T cells in PBSC allografts correlates with improved GVHD-free and progression-free survival

Splenic and Circulating Human T Follicular Helper Cell Regulation By B Cell Depleting Therapy during Immune Thrombocytopenia

Larger Number of Invariant Natural Killer T-Cells in Allogeneic Peripheral Blood Stem Cell Grafts Is Associated with Improved Graft-Versus-Host Disease-Free, Progression-Free Survival after Allogeneic Stem Cell Transplantation

Liver X Receptor Agonists: A Potential Treatment for Blastic Plasmacytoid Dendritic Cell Neoplasm

How to Treat Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Patients : Results on 86 Patients of the French BPDCN Network

Biological Description of 109 Cases of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) from the French Network of BPDCN

Splenic TFH expansion participates in B-cell differentiation and antiplatelet-antibody production during immune thrombocytopenia

Preclinical Studies Of SL-401, a Targeted Therapy Directed To The Interleukin-3 Receptor (IL3-R), In Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Potent Activity In BPDCN Cell Lines, Primary Tumor, and In An In Vivo Model

Preferential splenic CD8 + T-cell activation in rituximab-nonresponder patients with immune thrombocytopenia

Plasmacytoid Dendritic Cells (PDC) and Th17 Immune Response Contribution in Skin Acute Graft-Versus-Host-Disease (GVHD)

Failure of Rituximab in Immune Thrombocytopenia Is Associated with the Activation of Splenic CD8 T Cells

Plasmacytoid Dendritic Cells (PDC) and Th17 Immune Response Contribution in Gut Acute Graft-Versus-Host-Disease (GVHD)

The IL-3Rα-Targeted Drug SL-401 Selectively Kills Blastic Plasmacytoid Dendritic Cell Neoplasm Cells

Peripheral Blood Stem Cell Grafts Mobilized by G-CSF and Plerixafor in Comparison to G-CSF Alone: Phenotypic and Functional Characterization,

Successful mobilization and engraftment of PBSCs derived from donor cord blood cells after a previous allogeneic RIC single unrelated cord blood transplantation

Infusion of Ex-Vivo Expanded Donor T Cells To Improve Graft-Derived T-Cell Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation.

Endothelial Cell-Derived Microparticules (EMPs) Can Induce In Vitro Maturation of Both Plasmocytoid and Myeloid Dendritic Cells.

Identification of BDCA-2 and High Levels of CD123 Expression as Useful Markers for the Diagnosis of Plasmacytoid Dendritic Cell Leukemia.

Quality Assurance Improvement during Accreditation Process of a French Cord Blood Bank: FACT No Fiction.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only